Lead Fibrosis Program

About Nosis Bio

Nosis Bio is an AI-driven biotech pioneering a novel platform, Connexa, to design and deliver cell-specific RNA therapeutics. The platform leverages a proprietary 'receptome atlas' and AI models to discover novel targetable receptors and design optimized ligand-payload combinations, aiming to rapidly advance programs from discovery to in vivo validation. The company has a preclinical pipeline focused on fibrosis, immunology, and inflammatory diseases, and has secured a strategic collaboration with Johnson & Johnson in neurology, positioning it to expand RNA medicine beyond the liver and muscle.

Therapeutic Areas

Other Fibrosis Drugs